GraphWear Technologies Inc.

GraphWear Technologies Inc. is a healthcare technology company based in San Francisco, founded in 2015. The company specializes in non-invasive, needle-free glucose monitoring solutions designed to enhance diabetes management and chronic condition monitoring. Their flagship product, Bios, utilizes advanced nanotechnology to detect glucose and other biomolecules from the skin's surface, eliminating the need for traditional blood draws. The Bios device can be worn as a wrist sensor or a patch on the lower abdomen, providing a convenient and pain-free alternative for continuous glucose monitoring. GraphWear is currently conducting clinical trials to compare its readings with traditional blood glucose measurements and is working towards obtaining FDA 510(k) clearance for its seven-day use in individuals with Type 1 and Type 2 diabetes. The company plans to sell the Bios device directly to consumers and may offer subscription services for continuous monitoring and data analytics, along with partnerships with healthcare providers.

• Employees9
• Founded2015
• Annual Revenue$1500000
• Total Funding$25300000